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Abstract
Objective—To assess the use of the Medicare Obesity coverage benefit (MOB) by a licensed 
physician or associate provider in an outpatient setting in older adults.
Methods—We used a serial cross-sectional analysis of fee-for-service Medicare claims (2012 
and 2013) to assess the use of the MOB. Number and proportion of Medicare beneficiaries over 
age 65 using the benefit were assessed. Correlation between state-obesity rates and MOB uptake 
was determined based on state-specific obesity prevalence data from the Behavioral Risk Factor 
Surveillance System.
Results—There were 27,338 (0.10%) Medicare beneficiaries over age 65 in 2012 using the 
MOB, slightly more in 2013 (n=46,821 [0.17%]). Mean age of MOB users in both years was 73 
years and 62% were females. Use declined with older age and was highest in the Northeast and 
lowest in the Midwest. High state obesity prevalence was not correlated with higher uptake of the 
MOB. Estimated proportion of persons with obesity using the MOB was 0.35% and 0.60% in 
successive years. We observed a mean of 1.99 and 2.16 claims/MOB user.
Conclusions—While the rate of MOB use increased in the second full year of its 
implementation, few are availing themselves of this benefit.
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INTRODUCTION
Prevalence rates of obesity in the United States continue to be high, approaching 35% in the 
general population(1). The risks associated with obesity have been well documented and 
include cardiometabolic(2), functional(3) and mortality risks(4) that are critically important 
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public health concerns. Primary care practitioners are well positioned to deliver important 
lifestyle interventions as front-line clinicians yet barriers of insurance reimbursement, time 
and inadequate skills have plagued the ability to intervene at this level(5, 6).
In November 2011, the Centers for Medicare and Medicaid Services (CMS) decided to 
cover counseling for obesity in eligible Medicare beneficiaries whose body mass index 
(BMI) was ≥30kg/m2. Clinicians, defined as physicians, associate providers (nurse 
practitioners, physician assistants), or clinical nurse specialists, can provide 22 targeted, 15-
minute intensive behavioral therapy counseling visits in a continuous 12 month period. The 
goal of this benefit is to achieve a mean weight loss of 3kg in participating Medicare 
beneficiaries. Medicare based their coverage determination on a number of targeted clinical 
lifestyle intervention trials(7, 8, 9, 10, 11, 12, 13, 14).
The diagnosis and care of persons with obesity and the delivery of intensive behavioral 
therapy in a primary care setting is rare, providing a considerable opportunity for 
treatment(15, 16). While the MOB was considered a success in recognizing the importance 
of obesity as a disease, others have argued a number of shortcomings(17). Practice 
management barriers lead to challenges in fee-for-service reimbursement models, including 
providing the intensity of visits in busy primary care practices and relatively poor 
reimbursement levels(18, 19). The aim of this current study was to use national Medicare 
claims data to assess the uptake of the benefit over the first two years of implementation and 
to test whether the uptake was associated with state-level obesity rates. We hypothesized that 
we would observe higher use in areas with higher obesity rates.
METHODS
A cross-sectional analysis of fee-for-service Medicare claims was used to report on the first 
two years (2012 and 2013) of implementation of the Medicare Obesity Benefit (MOB) 
covered under Medicare Part B. We included 100% fee-for-service Medicare beneficiaries 
aged 65 and older enrolled in Parts A and B. Use of the MOB was assessed in two different 
manners: a) the presence of at least one visit in the Carrier file billed for a Common 
Procedural Treatment code of G0477 (the MOB); or b) the presence of the G0477 code with 
an ICD-9 code of Obesity (278.00, 278.01, 278.03, 278.01, V85.3-V85.4), which is 
consistent with the regulatory requirements. As the MOB reimburses up to 22 visits, as an 
exploratory analysis, we determined the average number of MOB visits per person per year. 
All demographic data was obtained from the Medicare denominator file including sex, race/
ethnicity and age on January 1st of each respective year. Results were aggregated nationally 
and stratified by age, sex, ethnicity and region (Northeast, South, West, Midwest). The 
number of beneficiaries using the MOB and the number of MOB claims per MOB user were 
also determined.
We then ascertained the rate of MOB using prevalence rates of obesity using data from the 
2012 Behavior Risk Factor Surveillance System (http:www.cdc.gov/brfss). This dataset is 
coordinated and managed by the Centers for Disease Control that collects state data from US 
residents regarding their health-related risk behaviors, chronic health conditions and use of 
preventive services using telephone surveys. National obesity rates were determined using 
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the crude individual state rates to determine the proportion of Medicare beneficiaries eligible 
for the MOB, nationally. We estimated the number of beneficiaries with obesity per state as 
the product of the state-specific prevalence rate and the total number of fee for service 
Medicare beneficiaries in the state. The rate of MOB uptake among potentially eligible 
beneficiaries was determined as the ratio of the number of beneficiaries availing themselves 
of the benefit to the estimated state prevalence of obesity in eligible Medicare beneficiaries. 
Data was suppressed for states with fewer than 11 observations and indicated in the text or 
figure accordingly. As BRFSS data was only available in aggregate for those over the age of 
65 years, we estimated the prevalence rate of obesity to equal this across all age categories 
(<70 to 85+). The correlation between state-specific obesity rates and the rate of MOB 
uptake was determined. All data analyses were performed using SAS (version 9.4, Cary, 
NC) and Microsoft Excel 2013 (Redmond, WA); the map was made with ESRI ArcGIS 
10.0. The study was approved by the Committee for the Protection of Human Subjects at 
Dartmouth.
RESULTS
In 2012, there were 27,338 (0.10%) Medicare beneficiaries using the MOB which increased 
slightly to 46,821 (0.17%) in 2013 (Table 1) using any G0477 coding. If one used the G0477 
code in combination with an ICD-9 code for obesity, as should occur according to the billing 
rules, the number of users was 75-80% lower (Supplementary Table S1). In the remainder of 
the analyses, we report the use of the G0477 code without regard to accompanying ICD-9 
code. In those using the MOB, mean age was 75.6 years. MOB users were more likely 
female (62%) or Black (10.0%), as compared to the overall population (57% and 8%, 
respectively) in both years. Overall, sex, race, age, and region-specific uptake increased in 
2013. In those using the MOB benefit, there was a higher proportion of eligible older adults 
aged <70 years old using the benefit (0.42%) than those aged ≥85 years old (0.15%) in 2012. 
There were similar trends observed in 2013 (0.74% and 0.24%).
We present in Figure 1 a map of the proportion of MOB users by state in the 2013 year. 
Estimated proportion of individuals with obesity using the MOB nationally increased from 
0.17% to 0.60%. The number of MOB claims in the 2012 and 2013 years were 54,330 and 
101,290, respectively. Our exploratory analysis of demonstrated that there was a mean of 
1.99 claims/person in 2012 that increased to 2.16 in the calendar year 2013. In both years, 
there was a higher proportion of beneficiaries and claims using the MOB in the Northeast; 
fewer were using the benefit in the Midwest. There were only 6 states that had mean number 
of visits of 3 or more claims. We did not observe a relationship between rate of state obesity 
and MOB uptake rate.
DISCUSSION
In the first two years of CMS Obesity benefit, an estimated 0.35-0.60% of eligible Medicare 
beneficiaries with obesity used this service. We observed variability in our results depending 
on the manner the provider billed this benefit. Use of MOB increased in the second year, but 
remained low. The use of the benefit did not appear to be related to the prevalence of obesity 
Batsis and Bynum Page 3
Obesity (Silver Spring). Author manuscript; available in PMC 2017 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
in each state. On average, MOB users had 2 MOB visits per year when the benefit covers a 
maximum of 22 sessions.
The increasing trend in beneficiaries using the MOB is consistent with what has been 
observed when other regulatory coverage determinations have been implemented. The 
Medicare hospice benefit was enacted in August 1982 for coverage starting in November 
1983. During the fiscal year 1984, there were 2,000 beneficiaries electing the benefit, a 
number that tripled during the second year of the program, reaching more than 11,000 in the 
third fiscal year(20). The Welcome to Medicare Visit was first introduced in 2005. In 2006, 
approximately 2.9% of beneficiaries took advantage of this benefit (21), which increased to 
3.2% in 2007. Lastly, even in a large health system, fewer than 3.2% of beneficiaries used 
the Medicare Annual Wellness Visit following implementation of Affordable Care(22). If the 
MOB follows the pattern of previous new benefits, we expect that the rates will continue to 
rise over time. Yet providers may not be integrating MOB visits within their practice due to 
the high frequency of visits expected or because of the complexity of the documentation 
requirements.
We did not observe a relationship between MOB uptake and the number of Medicare 
beneficiaries eligible to use this benefit nor did we observe a strong relationship between 
regional or state obesity prevalence rates with number of MOB beneficiaries or number of 
claims. One reason could be that the counts were too low to detect whether a correlation 
existed. Such variation has been observed in other studies examining cardiovascular health 
which may be partially impacted by individual and state level factors(23, 24). In fact, a 
previous study has demonstrated variation in prevalence of obesity and medical practice 
patterns regarding weight management advice(25). The delivery of IBT and care of persons 
with obesity can be challenging in primary care along with the manner in which obesity is 
diagnosed and documented likely causing, in part the low counts observed. Integrating 
frequent visits into busy practices may be impractical and physicians receive little formal 
training on provision of weight counseling. For instance, if a primary care provider delivered 
the service to half of thei Medicare patients with obesity (n=90 estimated based on ~30% 
with obesity in a panel of 2,000 patients of whom 30% are Medicare beneficiaries), it would 
require 495 hours of counseling using IBT (15 minutes × 22 visits × 90 patients) per year. 
An alternative model structuring the use of allied-health staff, including nurses and 
dieticians, that can provide such services may increase the possibility for wide-spread 
dissemination in primary care
An important finding in our analysis was that the G0477 code was billed in different 
manners. The regulatory coverage determination put forth by Medicare stated that the G0477 
code must be billed together with an ICD-9 code of obesity. Our results reflect that should 
we have based our results on this combination of G0477/ICD-9 documentation, only a small 
fraction of individuals would have been covered. Even more important is that the incorrect 
billing may account for the provider to believe that is too low. These preliminary findings 
suggest an opportunity for using the electronic health record to set up prompts and alerts to 
support correct billing procedures.
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The proportion of beneficiaries using the MOB was lower in higher age groups. While we 
cannot determine why this occurs with this data, a number of factors are possible. Primary 
care clinicians are ill-equipped at counseling and managing obesity in younger 
populations(26); their abilities may be even further challenged in recommending weight loss 
in older adults due to the limited, large randomized controlled trial evidence available, none 
of which are in a primary care setting (14, 27, 28, 29, 30). Providers may resist counseling 
older adults toward weight loss because of concern over conflicting reports suggesting a 
relationship between weight loss and mortality(31, 32, 33) and concern about potential 
effects on loss of muscle and bone loss that can lead to an increased risk of disability(14, 34, 
35). Women avail themselves of the MOB more so than men. Woman are known to report 
higher levels of body image dissatisfaction, more depression and are more likely to seek 
weight loss therapy(36, 37) and we suspect that our findings may be, in part, due to these 
phenomena.
We acknowledge a number of limitations of this study. Our results may underestimate the 
overall uptake of all visits for obesity counseling. For the MOB claim to be reimbursed, an 
ICD-9 code of obesity along with the G0477 code must be documented on the claim. Our 
analysis attempted to integrate beneficiaries with a G0477 code in their billing history and 
presented the data in aggregate. As the number of beneficiaries across the country increase 
in the use of the MOB, future analyses will eliminate this problem. Second, patients with 
obesity may receive care and/or counseling for their weight that is integrated into other visits 
which would not be captured in administrative data. We acknowledge that we may have 
missed a small percentage of cases in physician visits that are present only in the hospital 
outpatient file (ie: federally qualified and rural health centers) but these visits account for 
~2% of all visits nationally. Third, our data on claims per beneficiary is subject to bias as we 
would not have a full calendar year following 2013 to capture all the required visits. 
However, we would expect the first visit to occur evenly across the year and that 
beneficiaries would be getting more frequent visits. A mean of 2 visits/beneficiary, while 
exploratory, suggests that the benefit is underutilized. Fourth, our data on obesity uptake rate 
was based on obesity prevalence rates in the general population, not specific to older adults, 
although prevalence rates in a geriatric population is known to approximate that of the 
general population(1). Last, while we present data on the uptake by non-black/black, our 
results do not accurately allow for further delineation by other ethnicities.
As our society ages, the number of people with obesity will continue to increase 
dramatically. There is a great value in understanding the true scope of using this important 
benefit, particularly in the primary care setting where obesity management predominantly 
occurs. Such a federal policy measure is important from a public health standpoint. 
However, the paucity of cases and claims provide evidence that individuals are not taking 
advantage of the benefit. The lack of uptake may be due to a lack of provider knowledge, 
need for more time for diffusion into practice, or the way in which the MOB benefit is 
structured is needed. If the MOB continues to be poorly used in practice, other strategies 
such as incorporating telemedicine or allowing allied health staff to deliver intensive 
behavioral therapy, could be considered to increase use of interventions to reduce obesity. A 
greater understanding of encouraging older individuals with obesity is needed to use this 
benefit. Whether this IBT benefit is effective at reducing obesity, its clinical outcomes and 
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its consequences in clinical practice are important areas of future research. In particular, 
little is known about the integration of IBT into existing geriatric care models. Establishing 
the relationship of weight loss counseling by primary care providers to health promotion and 
long-term obesity outcomes is needed in older adults with obesity.
Conclusion
While there has been a small, steady rise in the use of the CMS Medicare Obesity benefit, 
utilization and uptake across the United States remains very low, and is not correlated with 
high obesity rates. Future use of the MOB in beneficiaries is needed prior to assessing a 
meaningful impact in older adults with obesity.
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What is known?
• Obesity in Older Adults is an important public health concern that 
impacts functional impairment, morbidity and mortality;
• The Centers for Medicare & Medicaid Services introduced a benefit for 
treating older adults with obesity within a primary care setting;
• While Intensive Behavioral Therapy is effective in promoting weight 
loss, its delivery is rare in a primary care setting.
What this study adds?
• The number of beneficiaries using the Medicare Obesity Benefit is low 
in successive years following implementation;
• While the use of the benefit is not higher in states with higher obesity 
rates, it rose slightly in 2013;
• Rates of use are lower in the older adult age group.
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Figure 1. Map of Relative Uptake of Medicare Obesity Benefit, by state, 2013
The proportion of number of beneficiaries using the Medicare Obesity Benefit and the 
number of estimated beneficiaries with obesity eligible for the benefit by state in the United 
States in the year 2013. Data was suppressed in 10 states.
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